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SUPPLEMENTARY NOTES
ABSTRACT
Several recent studies have indicated that decreased levels of the MCM2-7 DNA replication proteins can lead to genomic instability (GIN) and cancer formation. Interestingly, genetic or RNAi-mediated depletion of one MCM has been demonstrated to cause decreases in other MCMs, presumably as a consequence of MCM heterohexamer destabilization. In the first year of my training grant, my research results show that in cells bearing only the Mcm4 Chaos3 cancer susceptibility allele, the cause for reduced MCM protein levels is related to decreased Mcm2-7 and 10 mRNA. Despite being present at levels far exceeding that required for DNA replication under normal circumstances, we found that heterozygosity for 2 or more different MCMs caused genomic instability, and in the cases of MCM2, MCM6 and MCM7, synthetic lethality in conjunction with Mcm4
Chaos3 homozygosity. These data suggest that proper stoichemistry of MCM components is carefully regulated, and that relatively minor disregulation or destabilization of MCM levels can have serious consequences for survival or cancer susceptibility in whole animals.
Introduction:
In eukaryotes, DNA synthesis begins at multiple sites along chromosomes called replication origins. In late mitosis to early G1 phase, replication origins are selected and bound by the hexameric origin recognition complex (ORC). ORC then recruits the initiation factors CDC6 and CDT1, which in turn are required for loading of the MCM2-7 complex, thereby forming the "pre-replicative complex" (pre-RC). The formation of preRCs is termed origin "licensing" and this allows origins to gain competency for a single round of DNA synthesis before entering S phase. MCM2-7 is a hexamer of six distinct but structurally-related minichromosome maintenance (MCM) proteins. In vivo and in vitro evidence indicates that the MCM2-7 complex is the replicative helicase (Bochman & Schwacha, 2008; Labib et al, 2000; Moyer et al, 2006) .
MCM2-7 proteins exist abundantly in proliferating cells, and are bound to chromatin in amounts exceeding that which is present at active replication origins or which is required for complete DNA replication. Although many studies showed that drastic decreases in MCMs are tolerated by dividing cells, there are certain deleterious consequences. A reduction in MCM proteins reportedly causes decreased usage of certain ARSs (Lei et al, 1996) , precipitating genome instability in yeasts. More recently, it was found that in Xenopus extracts and mammalian cells, excess chromatin-bound MCM2-7 complexes occupy dormant or "backup" origins that are activated under conditions of replication stress, compensating for stalled or disrupted primary replication forks. A depletion of these backup licensed origins could potentially lead to incomplete DNA replication and genetic aberrations (Ge et al, 2007; Ibarra et al, 2008; Woodward et al, 2006 (Pruitt et al, 2007) .
In Chaos3 allele in a similar manner, and that the cell does not appear to compensate for lack of chromatin-bound or cytosolic MCMs by shuttling between the two compartments (Fig 1) .
Shima et al hypothesized that MCM4 Chaos3 might be unstable, causing dissociation of MCM2-7 hexamers and subsequent degradation of the individual proteins (Shima et al, 2007a derived from littermates in all cases) revealed that transcript levels for each of these genes in mutant cells was 51-65% of WT, in line with that of protein decreases (Fig. 2a) .
These mRNA decreases were specific to the Mcms, as the 7 housekeeping genes analyzed were not altered significantly (Fig. 2b) . These data suggest that the decrease of MCM proteins in Mcm4 Chaos3/Chaos3 cells is the result of decreased mRNA.
The reduction of Mcm mRNAs could be due to decreased transcription or increased postranscriptional degradation. To test the former, I used quantitative real-time RT-PCR (qRT-PCR) to measure the levels of heterogeneous nuclear RNA (hnRNA; pre-spliced transcripts), which, due to its short half-life, reflects transcriptional activity. In contrast to the mRNA (Fig. 2) , Mcm hnRNA levels in Mcm4 Chaos3/Chaos3 and WT MEFs were approximately the same (Fig. 3a) , implying that post-transcriptional elimination or destabilization of MCM mRNAs underlies the Mcm mRNA and protein decreases.
However, it is conceivable that transcription is decreased but splicing is inhibited proportionally, which would lead to apparently normal hnRNA levels but decreased mRNA.
To address this, I performed two experiments to examine Mcm transcriptional activity.
First, I measured RNA polymerase II occupancy within Mcm transcriptional units by chromatin immunoprecipitation followed by quantitiative PCR (ChIP-qPCR). The levels in mutant cells were similar to or higher than in WT (Fig. 3b) . In a second approach, I
cloned the putative promoter regions (-1 to -300 bp) of Mcm2, Mcm5 and Mcm7 upstream of a firefly luciferase reporter, transfected these transiently into WT and Mcm4
Chaos3/Chaos3
MEFs, and measured luciferase levels. There were no significant differences between control and WT cells for any of the promoters (Fig. 3c) . The combined data indicate that the lower Mcm mRNA levels in Chaos3 cells are not due to decreased transcription.
Task 2: Determine if decreased levels of various MCM proteins cause genomic instability (GIN) and cancer predisposition in mouse models.
The Mcm4
Chaos3 allele was identified in a forward genetic screen for mutations causing elevated micronuclei (MN) in red blood cells, an indicator of GIN (Shima et al, 2007a (Shima et al, 2007a) , each of these alleles proved to be recessive embryonic lethal (Table 1) . Heterozygosity for each gene trap allele caused elevated MN (Fig. 4) . Compound heterozygosity further increased MN on average, as did heterozygosity for 3 or more gene traps (Fig. 4) .
Previous studies showed that reductions of particular MCMs in cells or mice reduces the levels of other MCMs, causing GIN, cancer, and developmental defects. However, the reduction in MCM levels required to precipitate these consequences, and whether there is a threshold effect, is unclear. For example, the early-onset lymphoma and stem cell deficiency phenotypes in mice with a hypomorphic MCM2 allele (Mcm2 IRES-CreERT2 ) occur in homozygotes having 35% of WT MCM2 protein, but not heterozygotes (62% of WT) (Pruitt et al, 2007) . Cells from these homozygotes also showed a 21% reduction of
MCM7. C3H-Mcm4
Chaos3/Chaos3 mice are developmentally normal, but Mcm4
Chaos3/-animals die in utero or neonatally depending on genetic background (Shima et al, 2007b) . These cases support the idea that there is a replication licensing threshold effect with respect to the cancer and developmental phenotypes.
To explore the consequences of incremental MCM reductions on viability and cancer, Gt /+ mice (a cohort of 26) began dying at 2 months of age, and all were dead (or sacrificed when they appeared moribund)
by 7 months of age (Fig. 6 ). Necropsies revealed lymphomas or apparent leukemias in 13 of these animals, 5 had enlarged spleens, 3 could not be recovered for proper analysis, and 4 had no clear cause of death. Consistent with previous studies (Shima et al, 2007a) , 
